KEROS THERAPEUTICS IN
58,55
27-ноября-24 15:45:00
15 мин. задержка
Акции
+1,16
+2,02%
Сегодняшний диапазон
56,78 - 58,81
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences
26 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the Guggenheim Healthcare Innovation Conference
06 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
05 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Appoints Yung H. Chyung, M.D., as Chief Medical Officer
16 окт 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
12 сен 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Update on Enrollment in the Phase 2 TROPOS Trial
03 сен 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences
28 авг 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Reports Second Quarter 2024 Financial Results
07 авг 2024 15:01:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Leadership Updates
17 июн 2024 15:01:02 Источник Nasdaq GlobeNewswire
-
17 июн 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics to Host a Corporate Update Conference Call and Webcast
04 июн 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare Conference
03 июн 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors
28 май 2024 15:01:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the 29th Annual Congress of the European Hematology Association
14 май 2024 09:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
08 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
14 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at Leerink Partners 2024 Global Biopharma Conference
05 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
28 фев 2024 15:01:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics To Present at Pulmonary Vascular Research Institute 2024 Annual Congress
29 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Closing of Upsized Public Offering of Common Stock
09 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >